AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitabeat-M Tablet

Prescription Icon
Prescription Required

Marketer

Life Drug Pharmaceutical

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitabeat-M Tablet

Combiflex-D tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially decreasing the risk of cardiovascular events. Combiflex-D may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used concurrently with insulin or sulfonylureas; therefore, understanding hypoglycemia recognition and management is essential. This medication isn't universally suitable. Prior to initiating treatment, inform your physician of any pre-existing conditions such as hepatic, renal, or cardiac disease, pancreatic disorders, or excessive alcohol consumption. Pregnant or lactating individuals should seek medical counsel before starting treatment. Drug interactions are possible; therefore, complete disclosure of all medications is vital for patient safety. Alcohol should be minimized due to its potential to further reduce blood sugar levels. Regular monitoring of renal function and blood glucose will be performed throughout treatment.

Uses of Sitabeat-M Tablet

Managing type 2 diabetes

Major Benefits of Sitabeat-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sitabeat-M Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Sitabeat-M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitabeat-M Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Sitabeat-M Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Sitabeat-M Tablet works:

Sitabeat-M tablets contain sitagliptin and metformin, working synergistically to manage blood glucose levels. Sitagliptin boosts insulin production by the pancreas, enhances the body's insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Sitabeat-M Tablet and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitabeat-M Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitabeat-M tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

The use of Sitabeat-M Tablets requires careful consideration in individuals with impaired kidney function, potentially necessitating dose modification. Physician consultation is advised. Sitabeat-M Tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Use of Sitabeat-M Tablets is inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitabeat-M Tablet :

Should you forget a dose of Sitabeat-M Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitabeat-M Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Sitabeat-M Tablet

Sitabeat-M Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with a healthy diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18 years old.
Prolonged Sitabeat-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitabeat-M Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Sitabeat-M Tablets are contraindicated in patients with known hypersensitivity to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabeat-M Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Yes, Sitabeat-M Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid. Also known as metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitabeat-M and seek immediate medical attention.
Sitabeat-M Tablet combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitabeat-M Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Sitabeat-M Tablets are contraindicated in patients with known hypersensitivity to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabeat-M tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitabeat-M) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitabeat-M Tablet use can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the label's storage instructions. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitabeat-M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitabeat-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitabeat-M Tablets are contraindicated in patients with hypersensitivity to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabeat-M tablets and alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin + Metformin (like Sitabeat-M Tablet) can cause lactic acidosis (MALA), a serious medical emergency characterized by excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitabeat-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitabeat-M Tablet
84
MRP 98
14% off